Imbruvica (ibrutinib) - AbbVie, J&J
emavusertib (CA-4948) - Curis
https://ash.confex.com/ash/2023/webprogram/Paper189746.html
 
Christian Grommes, MD1; Han Tun, MD2; Allison C. Rosenthal, DO3; Matthew A. Lunning, DO, FACP4; Radhakrishnan Ramchandren, MD5; Lucia Regales, PhD6; Wanying Zhao, PhD6; Maureen Lane, PhD6; Catherine Wang, MD6; Reinhard von Roemeling, MD6; Iris Isufi7; Lori A. Leslie, MD8; Grzegorz S. Nowakowski, MD9
 
Nov 3, 2023
 
Prev Next